Citation 2507

KARTAL,M: MITAINE-OFFER,AC: PAULULAT,T: ABU-ASAKER,M: WAGNER,H: MIRJOLET,JF: GUILBAUD,N: LACAILLE-DUBOIS,MA:. (2006). TRITERPENE SAPONINS FROM ERYNGIUM CAMPESTRE.. 69(7)

Citation Details

Title	TRITERPENE SAPONINS FROM ERYNGIUM CAMPESTRE.
Authors	KARTAL,M: MITAINE-OFFER,AC: PAULULAT,T: ABU-ASAKER,M: WAGNER,H: MIRJOLET,JF: GUILBAUD,N: LACAILLE-DUBOIS,MA:
Year	2006
Volume	69
Issue	7

Summary

Year: 2006

Journal: Unknown

Organisms and Their Experiments (1)

Eryngium campestre (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BARRIGENOL R-1,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-22-O-BETA-BETA-DIMETHYL-ACRYLOYL:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BARRIGENOL R-1,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-22-O-BETA-BETA-DIMETHYL-ACRYLOYL:BARRIGENOL R-1,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONYLRANOSYL-22-ANGELOYL:BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-1-O-ACETYL-22-O-ANGELOYL:BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-21-ACETYL-22-O-BETA-BETA-DIMETHYL-ACRYLOYL:	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BARRIGENOL R-1,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-22-O-BETA-BETA-DIMETHYL-ACRYLOYL:BARRIGENOL R-1,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONYLRANOSYL-22-ANGELOYL:BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-1-O-ACETYL-22-O-ANGELOYL:BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-21-ACETYL-22-O-BETA-BETA-DIMETHYL-ACRYLOYL:	WEAK ACTIVITY
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BARRIGENOL R-1,3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONYLRANOSYL-22-ANGELOYL:	None
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-1-O-ACETYL-22-O-ANGELOYL:	None
6	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-21-ACETYL-22-O-BETA-BETA-DIMETHYL-ACRYLOYL:	None
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-22-O-ANGELOYL-28-O-ACETYL:	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-22-O-ANGELOYL-28-O-ACETYL:	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BARRIGENOL,R-1: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCURONOPYRANOSYL-22-O-ANGELOYL-28-O-ACETYL:	INACTIVE

Show SPARQL Queries (1)